NVIDIA
NVDA
Tesla
TSLA
Palantir
PLTR
4
BigBear.ai Holdings
BBAI
5
Advanced Micro Devices
AMD
US Stock MarketDetailed Quotes
INDV Indivior
- 9.240
- +0.360+4.05%
Close Feb 28 16:00 ET
- 8.820
- -0.420-4.55%
Post 20:01 ET
1.15BMarket Cap-25.67P/E (TTM)
9.370High8.340Low2.96MVolume8.445Open8.880Pre Close26.80MTurnover3.02%Turnover RatioLossP/E (Static)124.14MShares22.53052wk High-5.60P/B906.34MFloat Cap7.33052wk Low--Dividend TTM98.09MShs Float26.500Historical High--Div YieldTTM11.60%Amplitude7.330Historical Low9.046Avg Price1Lot Size
Indivior Stock Forum
Game-Changing OUD Treatment Update: SUBLOCADE Now Offers 1-Hour Start Protocol
Unexpected FDA Delay: Indivior's SUBLOCADE Label Changes Face Setback Despite Clean Review
Indivior Provides Preliminary Q3 2024 Results; Updates FY 2024 Guidance; Group Continues to Expect SUBLOCADE Peak Net Revenue of >$1.5 Billion
RICHMOND, Va., Oct. 10, 2024 /PRNewswire/ -- Indivior PLC (Nasdaq/LSE: INDV) today announced preliminary Q3 2024 financial results and provided updated FY 2024 guidance.
• Group now sees lower than expected Q3 2024 and FY 2024 SUBLOCADE net revenue (NR) from a combination of faster initial adoption among treatment providers of the...
No comment yet